Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-021330
Filing Date
2017-04-20
Accepted
2017-04-20 18:01:39
Documents
1
Period of Report
2017-04-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v464725_form4.html 4  
1 OWNERSHIP DOCUMENT v464725_form4.xml 4 3349
  Complete submission text file 0001144204-17-021330.txt   4920
Mailing Address 3301 AGRICULTURE DRIVE MADISON WI 53716
Business Address 3301 AGRICULTURE DRIVE MADISON WI 53716 617-244-1616
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RIB-X PHARMACEUTICALS, INC. 300 GEORGE STREET, SUITE 301 NEW HAVEN CT 06511
Business Address
Longcor Jarrod (Reporting) CIK: 0001545565 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36598 | Film No.: 17773795